Veronica Sanchez Bulis, VP, Corporate Controller at Lyell Immunopharma, Inc. (LYEL), sold 254 shares at $23.12 ($6K) on 2026-02-10, disclosed to the SEC on 2026-02-11.
Open-market sale of $6k LYEL by VP, Corporate Controller. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| LYEL | SELL | 2026-01-06 | $74K | — | Filing → |
| LYEL | SELL | 2025-11-12 | $4K | — | Filing → |